Dr.Reddys Laboratories reported INR16.51B in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Aspen Pharmacare APN:SJ ZAR 3.88B 497M
Bharat Petroleum BPCL:IN INR 18.37B 25.73B
Cipla CIPLA:IN INR 12.18B 1.18B
Dr.Reddys Laboratories DRRD:IN INR 16.51B 350M
Reliance Infra RELI:IN INR 230.72B 26.93B
Sun Pharmaceuticals SUNP:IN INR 24.71B 590.4M
UPL UPLL:IN INR 15.15B 2.72B